BioTime (Alameda, California) said that Robert Butler, MD, has been elected to the company's board. Butler is the founder and president/CEO of the International Longevity Center-USA. BioTime makes blood plasma volume expanders, blood replacement solutions for hypothermic surgery, organ preservation solutions, and technology for use in surgery, emergency trauma treatment and other applications.

Cyberonics (Houston) said that Joseph Laptewicz has been nominated to stand for election to its board. Laptewicz will replace Jeffrey Schwarz, a director since 2007, who will resign his seat as of the company's annual meeting Sept. 25. Most recently, Laptewicz served for seven years as a director of Advanced Neuromodulation Systems. Cyberonics is a medical technology company with core expertise in neuromodulation.

MedQuist (Mount Laurel, New Jersey) reported that with the closing of the stock purchase agreement between Koninklijke Philips Electronics N.V. and CBaySystems Holdings, in which Philips has sold its ownership interest of about 69.5% in MedQuist to CBaySystems, several members of its board have resigned: Clement Revetti, Edward Siegel, Gregory Sebasky and Scott Weisenhoff. They have been replaced by Robert Aquilina, Frank Baker, Peter Berger and Michael Seedman, designated for election to the board by CBaySystems Holdings, according to its agreement with MedQuist. Additionally, Aquilina has replaced Sebasky as chairman of the board. Aquilina previously was an executive partner in a senior consulting role to S.A.C. Private Capital Group. Baker is a managing director and co-founder of SAC PCG. Berger is a managing director and co-founder of SAC PCG. Seedman is the founder of Seedman and Associates, a private equity firm. MedQuist is a medical transcription service organization.

No Comments